Benitec Biopharma (BNTC) Institutional Ownership $10.89 -0.60 (-5.22%) Closing price 05/18/2026 04:00 PM EasternExtended Trading$10.87 -0.02 (-0.18%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Benitec Biopharma (NASDAQ:BNTC)CurrentInstitutional OwnershipPercentage52.19%Number ofInstitutional Buyers(last 12 months)42TotalInstitutional Inflows(last 12 months)$116.71MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$9.82M Get BNTC Insider Trade Alerts Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data BNTC Institutional Buying and Selling by Quarter Benitec Biopharma Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Janus Henderson Group PLC2,876,380$30.72M0.0%-1.2%8.374% 5/18/2026ADAR1 Capital Management LLC17,500$186K0.0%N/A0.051% 5/5/2026 Bank of New York Mellon Corp43,489$463K0.0%+37.6%0.127% 4/27/2026 Simplify Asset Management Inc.562,242$5.99M0.1%+271.9%1.637% 2/18/2026 Suvretta Capital Management LLC11,548,351$155.56M3.2%+16.9%33.713% 2/18/2026 Quadrature Capital Ltd31,481$424K0.0%N/A0.092% 2/18/2026 Millennium Management LLC613,160$8.26M0.0%N/A1.790% 2/18/2026 Balyasny Asset Management L.P.651,558$8.78M0.0%N/A1.902% 2/17/2026 Schonfeld Strategic Advisors LLC262,205$3.53M0.0%+0.7%0.763% 2/17/2026 Burkehill Global Management LP150,000$2.02M0.1%N/A0.437% Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/17/2026 Infinitum Asset Management LLC898,871$12.11M1.7%+79.8%2.617% 2/17/2026 RA Capital Management L.P.1,850,000$24.92M0.3%N/A5.386% 2/17/2026 Adage Capital Partners GP L.L.C.2,120,672$28.57M0.0%+7.5%6.174% 2/17/2026 Royal Bank of Canada2,122$29K0.0%-41.2%0.006% 2/17/2026 Persistent Asset Partners Ltd20,753$280K0.1%N/A0.060% 2/16/2026 Squarepoint Ops LLC15,045$203K0.0%N/A0.044% 2/16/2026 Truvestments Capital LLC3,834$52K0.0%+156.5%0.011% 2/16/2026 MYDA Advisors LLC225,000$3.03M0.6%+221.4%0.655% 2/16/2026 Barclays PLC23,211$313K0.0%+9.1%0.068% 2/13/2026 Nantahala Capital Management LLC1,038,371$13.99M0.5%+23.9%3.031% 2/13/2026 Marshall Wace LLP35,688$481K0.0%N/A0.104% 2/13/2026 AWM Investment Company Inc.282,977$3.81M0.4%+54.7%0.826% 2/13/2026 Alyeska Investment Group L.P.750,000$10.10M0.0%N/A2.189% 2/13/2026 Siren L.L.C.775,000$10.44M0.3%N/A2.262% 2/13/2026 State Street Corp245,051$3.30M0.0%+12.2%0.715% 2/13/2026 Wells Fargo & Company MN16,262$219K0.0%+78.1%0.047% 2/12/2026 Jane Street Group LLC12,425$167K0.0%N/A0.036% 2/12/2026 HRT Financial LP13,288$178K0.0%N/A0.039% 2/11/2026 Empery Asset Management LP55,440$747K0.7%N/A0.162% 2/11/2026 Deutsche Bank AG12,307$166K0.0%-26.5%0.036% 2/11/2026 Franklin Resources Inc.2,197,305$29.60M0.0%-15.1%6.414% 2/10/2026 Goldman Sachs Group Inc.174,041$2.34M0.0%-10.5%0.508% 2/9/2026 Geode Capital Management LLC453,375$6.11M0.0%+3.4%1.323% 2/9/2026 Simplify Asset Management Inc.151,163$2.04M0.0%+92.0%0.441% 1/9/2026 SG Americas Securities LLC8,232$111K0.0%N/A0.024% 1/1/2026 JPMorgan Chase & Co.5,989$84K0.0%-12.4%0.018% 11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6,783$95K0.0%-14.3%0.026% 11/17/2025 Ameriprise Financial Inc.154,414$2.17M0.0%+40.5%0.588% 11/14/2025 Longaeva Partners L.P.37,537$527K0.1%-27.8%0.143% 11/13/2025 UBS Group AG99,941$1.40M0.0%+458.8%0.381% Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.👉 Unlock the ticker now and get it completely free.11/13/2025 BNP Paribas Financial Markets2,937$41K0.0%+44.5%0.011% 11/13/2025 Franklin Resources Inc.2,589,633$36.33M0.0%-4.1%9.865% 11/13/2025 Russell Investments Group Ltd.5,615$79K0.0%N/A0.021% 11/7/2025Vanguard Group Inc.992,114$13.92M0.0%+2.4%3.779% 11/3/2025 New York State Common Retirement Fund4,327$61K0.0%-46.6%0.016% 10/20/2025 Simplify Asset Management Inc.78,725$1.11M0.0%+13.8%0.300% 8/15/2025Bank of America Corp DE6,879$80K0.0%+2,255.8%0.026% 8/15/2025 Ameriprise Financial Inc.109,925$1.29M0.0%+219.4%0.419% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,915$93K0.0%N/A0.030% 8/13/2025 Marshall Wace LLP43,003$503K0.0%N/A0.164% 8/13/2025 New York State Common Retirement Fund8,100$95K0.0%N/A0.031% 8/12/2025 XTX Topco Ltd10,845$127K0.0%N/A0.041% 8/12/2025 Rhumbline Advisers20,858$244K0.0%+11,114.0%0.079% 8/12/2025 Franklin Resources Inc.2,701,443$31.61M0.0%-5.6%10.291% 8/12/2025 JPMorgan Chase & Co.6,838$80K0.0%N/A0.026% 8/8/2025 Police & Firemen s Retirement System of New Jersey3,225$38K0.0%N/A0.012% 8/8/2025 Geode Capital Management LLC415,211$4.86M0.0%+77.6%1.582% 8/7/2025 Simplify Asset Management Inc.69,173$809K0.0%-9.9%0.264% 6/27/2025 Goldman Sachs Group Inc.45,883$597K0.0%N/A0.175% 5/16/2025Goldman Sachs Group Inc.45,883$597K0.0%N/A0.196% 5/16/2025Infinitum Asset Management LLC1,125,000$14.64M4.7%+435.7%4.797% 5/16/2025AWM Investment Company Inc.137,977$1.80M0.2%+35.2%0.588% 5/15/2025MYDA Advisors LLC52,000$677K0.1%+4.0%0.222% 5/13/2025Informed Momentum Co LLC39,330$512K0.1%N/A0.168% 4/7/2025GAMMA Investing LLC77,605$1.01M0.0%+1,104.3%0.331% 2/26/2025Infinitum Asset Management LLC210,000$2.65M1.4%N/A0.895% 2/18/2025AWM Investment Company Inc.102,027$1.29M0.2%-83.7%0.439% 2/17/2025Suvretta Capital Management LLC8,960,009$113.17M3.9%+1.5%38.587% 2/17/2025Lion Point Capital LP62,000$783K4.1%+59.0%0.267% 2/17/2025Janus Henderson Group PLC2,616,427$33.27M0.0%+198.5%11.268% 2/17/2025Ameriprise Financial Inc.35,476$448K0.0%+138.4%0.153% 2/17/2025683 Capital Management LLC35,817$452K0.0%N/A0.154% 2/14/2025Schonfeld Strategic Advisors LLC260,417$3.29M0.0%-4.5%1.122% 2/14/2025Northern Trust Corp38,200$482K0.0%+54.2%0.165% 2/14/2025Adage Capital Partners GP L.L.C.1,972,524$24.91M0.0%+134.4%8.495% 2/14/2025MYDA Advisors LLC50,000$632K0.2%N/A0.215% 2/12/2025Geode Capital Management LLC197,096$2.49M0.0%+134.7%0.849% 2/12/2025Franklin Resources Inc.2,939,287$37.12M0.0%+269.0%12.658% 2/11/2025Simplify Asset Management Inc.76,337$964K0.0%-34.5%0.329% 11/16/2024Geode Capital Management LLC83,987$772K0.0%+31.3%0.795% 11/15/2024Janus Henderson Group PLC876,523$8.03M0.0%-2.7%8.300% 11/14/2024Suvretta Capital Management LLC8,829,053$81.14M2.6%+422.0%83.640% 11/14/2024Acuta Capital Partners LLC29,800$274K0.2%N/A0.282% 11/6/2024Simplify Asset Management Inc.116,535$1.07M0.0%+127.5%1.104% 10/7/2024GAMMA Investing LLC6,540$60K0.0%+20.3%0.070% 8/20/2024Nantahala Capital Management LLC841,395$5.88M0.3%N/A8.982% 8/13/2024Simplify Asset Management Inc.51,216$358K0.0%N/A0.547% 7/2/2024GAMMA Investing LLC5,438$38K0.0%+53.0%0.058% 5/16/2024Janus Henderson Group PLC244,491$1.27M0.0%+35.5%9.440% 11/15/2023Adage Capital Partners GP L.L.C.189,188$572K0.0%N/A7.419% Your $29.97 book is free today (Ad)Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.Normally $29.97. Today it's free. Grab your copy now.11/15/2022Empery Asset Management LP796,837$296K1.8%N/A2.848% 11/15/2022Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478% 11/14/2022Armistice Capital LLC1,555,039$578K0.0%N/A6.025% 11/14/2022Altium Capital Management LP658,796$245K0.1%N/A2.552% BNTC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BNTC shares? During the previous two years, 53 institutional investors and hedge funds held shares of Benitec Biopharma. The most heavily invested institutionals were Suvretta Capital Management LLC ($155.56M), Janus Henderson Group PLC ($30.72M), Franklin Resources Inc. ($29.60M), Adage Capital Partners GP L.L.C. ($28.57M), RA Capital Management L.P. ($24.92M), Nantahala Capital Management LLC ($13.99M), and Vanguard Group Inc. ($13.92M).Learn more on Benitec Biopharma's institutional investors. What percentage of Benitec Biopharma's stock is owned by institutional investors? 52.19% of Benitec Biopharma's stock is owned by institutional investors. Learn more on BNTC's institutional investor holdings. Which institutional investors have been buying Benitec Biopharma's stock? Of the 50 institutional investors that purchased Benitec Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Suvretta Capital Management LLC ($8.94M), Franklin Resources Inc. ($2.14M), RA Capital Management L.P. ($1.85M), Janus Henderson Group PLC ($1.74M), Infinitum Asset Management LLC ($1.52M), Adage Capital Partners GP L.L.C. ($1.28M), and Nantahala Capital Management LLC ($1.04M). How much institutional buying is happening at Benitec Biopharma? Institutional investors have bought a total of 8,799,340 shares in the last 24 months. This purchase volume represents approximately $116.71M in transactions. Which of Benitec Biopharma's major shareholders have been selling company stock? Of the 10 institutional investors that sold Benitec Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Franklin Resources Inc. ($663.42K), Janus Henderson Group PLC ($35.31K), Goldman Sachs Group Inc. ($20.32K), Longaeva Partners L.P. ($14.46K), Simplify Asset Management Inc. ($7.56K), Deutsche Bank AG ($4.44K), and New York State Common Retirement Fund ($3.77K). How much institutional selling is happening at Benitec Biopharma? Institutional investors have sold a total of 752,752 shares in the last 24 months. This volume of shares sold represents approximately $9.82M in transactions. Related Companies GLUE Major Shareholders AGIO Major Shareholders VIR Major Shareholders OCS Major Shareholders NTLA Major Shareholders PGEN Major Shareholders BCAX Major Shareholders HROW Major Shareholders DMRA Major Shareholders IMTX Major Shareholders This page (NASDAQ:BNTC) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
